Danny Luna
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 63 payments — averaging $26.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$224
- Sanofi$222
- NS Pharma, Inc.$134
- Mirum Pharmaceuticals, Inc.$108
- Ultragenyx Pharmaceutical Inc.$107
- AstraZeneca$104
- plus $738 from 20 others
What the payments were for
- Food & beverage$1,638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 8 | $224 |
| Sanofi | 8 | $222 |
| NS Pharma, Inc. | 5 | $134 |
| Mirum Pharmaceuticals, Inc. | 4 | $108 |
| Ultragenyx Pharmaceutical Inc. | 4 | $107 |
| AstraZeneca | 4 | $104 |
| Ipsen Biopharmaceuticals, Inc | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Soleno Therapeutics, Inc. | 2 | $67 |
| Amicus Therapeutics, Inc. | 2 | $59 |
| Immedica Pharma US, Inc. | 2 | $45 |
| Aucta Pharmaceuticals, Inc. | 2 | $42 |
| Cycle Pharmaceuticals Inc | 2 | $38 |
| UCB, Inc. | 1 | $34 |
| PTC Therapeutics, Inc. | 1 | $31 |
| Springworks Therapeutics, Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Pharming Healthcare, Inc. | 1 | $27 |
| Sarepta Therapeutics, Inc. | 1 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Albireo Pharma, Inc. | 1 | $24 |
| Sentynl Therapeutics, Inc. | 1 | $21 |
| Biogen | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Abiomed | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
How this compares
$1,638 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.
Other family in Miami
- Patrick SzarazMiami$327K
- Yamila MelendezMiami$212K
- Suzan RosenMiami$129K
- Felipe NovoaMiami$110K
- Pamela DudkiewiczMiami$89K
- Stacy FeemsterMiami$51K
- Estrella Moreno RodriguezMiami$30K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.